Literature DB >> 353682

Treatment of status asthmaticus in children with high doses and conventional doses of methylprednisolone.

H Harfi, A S Hanissian, L V Crawford.   

Abstract

Twenty-one children who were admitted to the hospital with status asthmaticus were assigned randomly to one of two groups. Children in group A received methylprednisolone sodium succinate intravenously, 30 mg/sq m every six hours (conventional dose), and those in group B received methylprednisolone sodium succinate intravenously 300 mg/sq m every six hours, until they were no longer wheezing, or for a maximum of four days. There were no significant differences in the outcome between the two groups. We conclude that there is no extra advantage in giving massive doses of corticosteroids over conventional doses in the treatment of severe asthma attacks.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 353682

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Controlled trial of intravenous corticosteroids in severe acute asthma.

Authors:  F Morell; R Orriols; J de Gracia; V Curull; A Pujol
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

2.  Effects of corticosteroids in acute severe asthma.

Authors:  N C Barnes
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

Review 3.  Status asthmaticus in adults.

Authors:  H Don
Journal:  Clin Rev Allergy       Date:  1985-02

Review 4.  Adrenal corticosteroids in the treatment of asthma.

Authors:  S C Siegel
Journal:  Clin Rev Allergy       Date:  1983-03

Review 5.  A 25-year perspective of status asthmaticus.

Authors:  H C Mansmann
Journal:  Clin Rev Allergy       Date:  1983-03

Review 6.  The management of status asthmaticus in infants and children.

Authors:  G Kurland; A B Leong
Journal:  Clin Rev Allergy       Date:  1985-02

7.  Randomised pragmatic comparison of UK and US treatment of acute asthma presenting to hospital.

Authors:  N J Innes; J A Stocking; T J Daynes; B D W Harrison
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

8.  Oral corticosteroids for wheezing attacks under 18 months.

Authors:  M S Webb; R L Henry; A D Milner
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

9.  Corticosteroids in acute severe asthma: effectiveness of low doses.

Authors:  S D Bowler; C A Mitchell; J G Armstrong
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.